info@seagull-health.com
SeagullHealth
语言:
search

Pramipexole(Sifrol)

Names
普拉克索
Indicatons
Used for the management of Parkinson’s disease and moderate-to-severe primary Restless Legs Syndrome (RLS).
Price:
Manufacturer:
Boehringer-Ingelheim
Dosage form:
TABLET
Validity period:
24 months

Reminder: The outer packaging is for reference only, please purchase and use under the guidance of a pharmacist. For read by medical and pharmaceutical professionals only.

Sifrol(Pramipexole) Instructions:Uses,Dosage, Side Effects

MIRAPEX is an oral tablet formulation containing the active moiety pramipexole dihydrochloride monohydrate, a non-ergot dopamine receptor agonist. It exhibits high specificity and full intrinsic activity at the D2 subfamily of dopamine receptors, with a particular affinity for the D3 receptor subtype. The medication is designed for managing specific neurological conditions by modulating dopaminergic pathways in the brain, leading to symptomatic relief.

Generic name
Pramipexole(Sifrol)
English name
Pramipexole
Alternative Names
普拉克索
Drug prices
Indications

Treatment of signs and symptoms of Parkinson’s disease.

Treatment of moderate-to-severe primary Restless Legs Syndrome.

Therapeutic Target
Dopamine receptors, with high affinity for the D₂ subfamily, particularly the D₃ receptor subtype.
Active Ingredients
Pramipexole dihydrochloride monohydrate
Dosage Form
TABLET
Specifications
250mcg * 30 tablets / box
Dosage and Administration

Parkinson’s Disease:

Initiate at 0.125 mg three times daily. Increase gradually every 5–7 days up to a maximum of 1.5 mg three times daily, based on tolerability and clinical response.

Adjust dosage in renal impairment according to creatinine clearance.

Restless Legs Syndrome:

Start with 0.125 mg once daily, 2–3 hours before bedtime. May increase every 4–7 days up to 0.5 mg daily if needed.

    Recommended articles
    Related articles
    How to Use Pramipexole
    Pramipexole is a non-ergot dopamine receptor agonist, mainly used for the treatment of Parkinson's disease (PD) and moderate-to-severe primary restless legs syndrome (RLS). Its efficacy and effect...
    How to Purchase Pramipexole
    Pramipexole is a non-ergot dopamine receptor agonist, primarily indicated for the treatment of Parkinson's disease and moderate-to-severe primary restless legs syndrome (RLS). Due to its unique ph...
    What Are the Side Effects of Pramipexole?
    Pramipexole is a non-ergot dopamine agonist used for the treatment of Parkinson's Disease and moderate-to-severe primary Restless Legs Syndrome (RLS). As a dopamine receptor agonist, while it impr...
    Precautions for Pramipexole Administration
    Pramipexole is a non-ergot dopamine receptor agonist used for the treatment of Parkinson's Disease (PD) and moderate-to-severe primary Restless Legs Syndrome (RLS). Its efficacy and safety are hig...
    Indications for Indications for Pramipexole
    Pramipexole is a non-ergot dopamine receptor agonist, primarily indicated for the treatment of Parkinson's Disease (PD) and moderate-to-severe primary Restless Legs Syndrome (RLS).Indications for ...
    New Drugs
    Infigratinib(Truseltiq)
    Infigratinib(Truseltiq)
    Treatment of previously treated, unresectable locally advanced or metastatic...
    Opicapone(Ongentys)
    Opicapone(Ongentys)
    Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
    Deflazacort(Emflaza)
    Deflazacort(Emflaza)
    Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
    Faricimab-svoa(Vabysmo)
    Faricimab-svoa(Vabysmo)
    Treatment of neovascular age-related macular degeneration, diabetic macular...
    Counselling Service
    Global Drug Search
    Clinical Research Recruitment
    Overseas Medical Treatment
    Remote Consultations
    Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
    Submit
    Business
    • Core products
    • Antitumor drugs
    • General drug
    • Antiviral drugs
    • Biological agents
    Contact Us 
    • mailbox:info@lucius.la
    Welcome to consult
    ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved